CZR CAESARS ENTMT CORP

Ownership history in Qube Research & Technologies Ltd  ·  31 quarters on record

AI Ownership Summary

Qube Research & Technologies Ltd reported CAESARS ENTMT CORP (CZR) in 31 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.17% in 2023 Q4. The latest visible filing shows CZR at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CZR ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Qube Research & Technologies Ltd's position in CAESARS ENTMT CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

CZR was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.17% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Qube Research & Technologies Ltd held CZR — position size vs. price
% of Fund (quarterly)    CZR price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 17 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 229,800 -9,800 -4.1% 0.01% $5.4M 2026-02-14 (Est.) $18.14
2025 Q4 ADDED 239,600 +76,900 +47.3% 0.01% $5.6M 2026-02-14 (Est.) $18.14
2025 Q3 REDUCED 162,700 -40,700 -20.0% 0.00% $4.4M 2025-11-14 $19.78
2025 Q3 REDUCED 203,400 -43,769 -17.7% 0.01% $5.5M 2025-11-14 $19.78
2025 Q3 ADDED 247,169 +129,169 +109.5% 0.01% $6.7M 2025-11-14 $19.78
2025 Q2 REDUCED 118,000 -61,800 -34.4% 0.00% $3.4M 2025-08-14 $25.53
2025 Q2 ADDED 179,800 +97,900 +119.5% 0.01% $5.1M 2025-08-14 $25.53
2025 Q1 ADDED 81,900 +38,100 +87.0% 0.00% $2.0M 2025-05-15 $30.31
2025 Q1 ADDED 43,800 +33,700 +333.7% 0.00% $1.1M 2025-05-15 $30.31
2024 Q4 REDUCED 10,100 -16,400 -61.9% 0.00% $338K 2025-02-14 $39.76
2024 Q4 REDUCED 26,500 -222,917 -89.4% 0.00% $886K 2025-02-14 $39.76
2024 Q2 ADDED 249,417 +232,817 +1402.5% 0.02% $9.9M 2024-08-14 $34.78
2024 Q1 ADDED 16,600 +16,200 +4050.0% 0.00% $726K 2024-05-14 $36.71
2024 Q1 REDUCED 400 -2,136,657 -100.0% 0.00% $17K 2024-05-14 $36.71
2024 Q1 ADDED 2,137,057 +251,168 +13.3% 0.15% $93.5M 2024-05-14 $36.71
2023 Q4 ADDED 1,885,889 +1,869,689 +11541.3% 0.17% $88.4M 2024-02-13 $42.45
2023 Q4 REDUCED 16,200 -891,830 -98.2% 0.00% $759K 2024-02-13 $42.45
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Qube Research & Technologies Ltd and CZR

These are the practical questions this page is built to answer before you even open the full history table.

How long has Qube Research & Technologies Ltd reported owning CZR?

Qube Research & Technologies Ltd reported CZR across 17 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported CZR position in Qube Research & Technologies Ltd's portfolio?

The largest reported portfolio weight for CZR was 0.17% in 2023 Q4.

What is the latest reported CZR position on this page?

The most recent filing on this page is 2025 Q4, when Qube Research & Technologies Ltd reported 229,800 shares, equal to 0.01% of portfolio, with an estimated market value of $5.4M.

What does the chart on this CZR ownership page compare?

The chart compares Qube Research & Technologies Ltd's quarterly CZR portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Qube Research & Technologies Ltd Holdings